Regional Anesthesia and Acute Pain ManagementRegional Anesthesia and Acute Pain ManagementРегионарная анестезия и лечение острой боли1993-65082687-1394Eco-Vector6469210.17816/RA64692ReviewsНаучные обзорыResearch ArticleThe role of an anesthesiologist in the pandemic of uncontrolled use of psychotropic drugsРоль врача-анестезиолога-реаниматолога в условиях пандемии неконтролируемого употребления психотропных препаратовhttps://orcid.org/0000-0001-5798-92099740-9109SvirskiiDmitrii A.СвирскийДмитрий Алексеевич
Russian Federation

Cand. Med. Sci., Associate professor

к.м.н., доцент

dsvirskiy@mail.ruhttps://orcid.org/0000-0002-2386-92818850-2071AntipinEduard E.АнтипинЭдуард Эдуардович
Russian Federation

MD, PhD, DSc

д.м.н.

vard67@mail.ruhttps://orcid.org/0000-0002-5138-36179673-1896ParomovKonstantin V.ПаромовКонстантин Валентинович
Russian Federation

MD, PhD

к.м.н.

kp-82@mail.ruhttps://orcid.org/0000-0001-8919-81962228-9911NedashkovskyEduard V.НедашковскийЭдуард Владимирович
Russian Federation

MD, PhD, DSc

д.м.н.

arsgmu@mail.ruOOO MDC of pain management & rehabilitationООО «МПЦ лечения боли и реабилитации»Northern State Medical UniversityСеверный государственный медицинский университетCity Clinical Hospital № 1 them. EE VolosevichПервая городская клиническая больница им. Е.Е. Волосевич1504202115210711705042021Copyright ©; 2021, Eco-VectorCopyright ©; 2021, ООО "Эко-Вектор"2021Eco-VectorООО "Эко-Вектор"https://rjraap.com/1993-6508/article/view/64692

In the modern world, the number of people using various psychotropic drugs increases every day. The situation that has been described in recent decades associated with the use of narcotic and not criminalized substances in international literature as the OPIOID + (plus) crisis.

According to statistics, over the past few years, officially registered deaths from drug overdose have exceeded 70,000 in the United States. Leading causes were synthetic opioids, psychostimulants, and cocaine. This includes prescription opioids, opiates, benzodiazepines, and antidepressants. All aforementioned drugs are used in combination with each other, with alcohol or psychotropic marijuana.

For humans, biological, social, and psychological factors are cause the initiation of psychoactive drugs.

Due to the lack of a well-functioning medical care system for patients with chronic pain, doctors of all specialties treat pain.

In this article, we consider the current situation with mind-altering drugs and apply the role of the anesthesiologist in reducing the growth rate of the opioid pandemic.

В современном мире количество людей, употребляющих различные психотропные препараты, увеличивается каждый день. Ситуация, которая развивается последние десятилетия в связи с употреблением наркотических и ещё не криминализованных веществ, описана в международной литературе как OPIOID+ crisis.

По статистике в США последние несколько лет ежегодное количество официально зарегистрированных смертей от передозировки наркотиками превышает 70000. Лидирующие позиции на пьедестале причин смертности занимают синтетические опиоиды, психостимуляторы и кокаин. Сюда же можно отнести и рецептурные опиоиды, опиаты, бензодиазепины и антидепрессанты. Как правило, все перечисленные выше препараты употребляют в сочетании друг с другом, с алкоголем или психотропной коноплёй.

Для большинства людей причиной начала употребления воздействующих на психику препаратов является боль, на формирование которой могут влиять биологические, социальные и психологические факторы.

В связи с отсутствием отлаженной системы оказания медицинской помощи пациентам с хронической болью, лечить боль начинают врачи всех специальностей, не имея возможности взаимодействия друг с другом.

В данной статье мы рассмотрим текущую ситуацию, связанную с употреблением изменяющих сознание препаратов, и попытаемся определить роль врача-анестезиолога-реаниматолога в снижении темпов роста опиоидной пандемии.

painpain managementopioid pandemicanesthesiologistresuscitatorбольлечение болиопиоидная пандемияврач-анестезиолог-реаниматологMerlin MD. COVER ARTICLE: Archaeological Evidence for the Tradition of Psychoactive Plant Use in the Old World. Economic Botany. 2003;57(3):295–323. doi: 10.1663/0013-0001(2003)057[0295:aeftto]2.0.co;2Merlin M.D. COVER ARTICLE: Archaeological Evidence for the Tradition of Psychoactive Plant Use in the Old World // Economic Botany. 2003. Vol. 57, N 3. P. 295–323. doi: 10.1663/0013-0001(2003)057[0295:aeftto]2.0.co;2Papadaki PG, Kritikos SP. The history of the poppy and of opium and their expansion in antiquity in the eastern Mediterranean area. Bulletin on Narcotics. 1967;19(4):5–10.Papadaki P.G., Kritikos S.P. The history of the poppy and of opium and their expansion in antiquity in the eastern Mediterranean area // Bulletin on Narcotics. 1967. Vol 19, N 4. P. 5–10.Sigerist HE. Laudanum in the Works of Paracelsus. Bull Hist Med. 1941;(9):530–544.Sigerist H.E. Laudanum in the Works of Paracelsus // Bull Hist Med. 1941. N 9. P. 530–544.Davenport-Hines R. Early History. The Pursuit of Oblivion. London: Weidenfeld & Nicolson; 2004.Davenport-Hines R. Early History. The Pursuit of Oblivion. London: Weidenfeld & Nicolson, 2004.Zheng Y. The Social Life of Opium in China, 1483–1999. Modern Asian Studies. 2003;37(1):1–39. doi: 10.1017/s0026749x0300101xZheng Y. The Social Life of Opium in China, 1483–1999 // Modern Asian Studies. 2003. Vol. 37, N 1. P. 1-39. doi: 10.1017/s0026749x0300101xHodgson B. In the Arms of Morpheus: The Tragic History of Laudanum, Morphine, and Patent Medicines. Buffalo, New York, USA: Firefly Books; 2001.Hodgson B. In the Arms of Morpheus: The Tragic History of Laudanum, Morphine, and Patent Medicines. Buffalo, New York, USA: Firefly Books, 2001.Courtwright D.T. Forces of habit drugs and the making of the modern world (1 ed.). Cambridge, Mass.: Harvard University Press; 2009.Courtwright D.T. Forces of habit drugs and the making of the modern world (1 ed.). Cambridge, Mass.: Harvard University Press, 2009.Mandel J. Mythical Roots of US Drug Policy – Soldier’s Disease and Addicts in the Civil War. Haight St. San Francisco; 1779.Mandel J. Mythical Roots of US Drug Policy – Soldier’s Disease and Addicts in the Civil War. Haight St. San Francisco, 1779.druglibrary.org [Internet]. “Opiate Narcotics”. The Report of the Canadian Government Commission of Inquiry into the Non-Medical Use of Drugs. Canadian Government Commission [cited 2021 May 5]. Available from: https://www.druglibrary.org/schaffer/library/studies/ledain/nonmed4.htmdruglibrary.org [Internet]. “Opiate Narcotics”. The Report of the Canadian Government Commission of Inquiry into the Non-Medical Use of Drugs. Canadian Government Commission. Дата обращения: 05.05.2021. Доступ по ссылке: https://www.druglibrary.org/schaffer/library/studies/ledain/nonmed4.htmMartin WR, Fraser HF. A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts. J Pharmacol Exp Ther. 1961;133:388–399.Martin W.R., Fraser H.F. A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts // J Pharmacol Exp Ther. 1961. Vol. 133, P. 388–399.Chou R, Cruciani RA, Fiellin DA, et al. Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. J Pain. 2014;15(4):321–337. doi: 10.1016/j.jpain.2014.01.494Chou R., Cruciani R.A., Fiellin D.A., et al. Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society // J Pain. 2014. Vol. 15, N 4. P. 321–337. doi: 10.1016/j.jpain.2014.01.494Mounteney J, Giraudon I, Denissov G, Griffiths P. Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe. Int J Drug Policy. 2015;26(7):626–631. doi: 10.1016/j.drugpo.2015.04.003Mounteney J., Giraudon I., Denissov G., Griffiths P. Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe // Int J Drug Policy. 2015. Vol. 26, N 7. P. 626–631. doi: 10.1016/j.drugpo.2015.04.003Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med. 1980;302(2):123. doi: 10.1056/nejm198001103020221Porter J., Jick H. Addiction rare in patients treated with narcotics // N Engl J Med. 1980. Vol. 302, N 2. P. 123. doi: 10.1056/nejm198001103020221Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain. 1986;25(2):171–186. doi: 10.1016/0304-3959(86)90091-6Portenoy R.K., Foley K.M. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases // Pain. 1986. Vol. 25, N 2. P. 171–186. doi: 10.1016/0304-3959(86)90091-6Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99(2):221–227. doi: 10.2105/AJPH.2007.131714Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy // Am J Public Health. 2009. Vol. 99, N 2. P. 221–227. doi: 10.2105/AJPH.2007.131714Cicero TJ, Inciardi JA, Munoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002–2004. J Pain. 2005;6(10):662–672. doi: 10.1016/j.jpain.2005.05.004Cicero T.J., Inciardi J.A., Munoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004 // J Pain. 2005. Vol. 6, N 10. P. 662–672. doi: 10.1016/j.jpain.2005.05.004Sites BD, Beach ML, Davis MA. Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users. Reg Anesth Pain Med. 2014;39(1):6–12. doi: 10.1097/AAP.0000000000000022Sites B.D., Beach M.L., Davis M.A. Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users // Reg Anesth Pain Med. 2014. Vol. 39, N 1. P. 6–12. doi: 10.1097/AAP.0000000000000022Zgierska A, Miller M, Rabago D. Patient satisfaction, prescription drug abuse, and potential unintended consequences. JAMA. 2012;307(13):1377–1378. doi: 10.1001/jama.2012.419Zgierska A., Miller M., Rabago D. Patient satisfaction, prescription drug abuse, and potential unintended consequences // JAMA. 2012. Vol. 307, N 13. P. 1377–1378. doi: 10.1001/jama.2012.419Cicero TJ, Ellis MS, Harney J. Shifting Patterns of Prescription Opioid and Heroin Abuse in the United States. N Engl J Med. 2015;373(18):1789–1790. doi: 10.1056/NEJMc1505541Cicero T.J., Ellis M.S., Harney J. Shifting Patterns of Prescription Opioid and Heroin Abuse in the United States // N Engl J Med. 2015. Vol. 373, N 18. P. 1789–1790. doi: 10.1056/NEJMc1505541Meier B. In Guilty Plea, OxyContin Maker to Pay $600 Million. The New York Times. 2007 May 10.Meier B. In Guilty Plea, OxyContin Maker to Pay $600 Million // The New York Times. 2007 May 10.Harriet R, Girion L, Glover S. You want a description of hell?’ OxyContin’s 12-hour problem. Los Angeles Times. 2016 May 5.Harriet R., Girion L., Glover S. You want a description of hell?’ OxyContin’s 12-hour problem // Los Angeles Times. 2016 May 5.Keefe PR. The Family That Built an Empire of Pain: The Sackler dynasty’s ruthless marketing of painkillers has generated billions of dollars – and millions of addicts. The New Yorker. 2017 October 23.Keefe P.R. The Family That Built an Empire of Pain: The Sackler dynasty’s ruthless marketing of painkillers has generated billions of dollars–and millions of addicts // The New Yorker. 2017 October 23.finance.yahoo.com [Internet]. Balsamo M, Mulvihill G. US officials: OxyContin maker to plead to 3 criminal charges [cited 2021 May 5]. Available from: https://finance.yahoo.com/news/ap-exclusive-oxycontin-maker-plead-134849205.html?guccounter=1finance.yahoo.com [Internet]. Balsamo M., Mulvihill G. US officials: OxyContin maker to plead to 3 criminal charges. Дата обращения: 05.05.2021. Доступ по ссылке: https://finance.yahoo.com/news/ap-exclusive-oxycontin-maker-plead-134849205.html?guccounter=1David C. The Opioid Timebomb: The Sackler family and how their painkiller fortune helps bankroll London arts. Evening Standart. 2018 March 20.David C. The Opioid Timebomb: The Sackler family and how their painkiller fortune helps bankroll London arts // Evening Standart. 2018 March 20.Mulvihill G. OxyContin maker Purdue Pharma files for bankruptcy as part of opioids settlement. USA Today 2019 September 15.Mulvihill G. OxyContin maker Purdue Pharma files for bankruptcy as part of opioids settlement // USA Today. 2019 September 15.Baldwin GT, Seth P, Noonan RK. Continued Increases in Overdose Deaths Related to Synthetic Opioids: Implications for Clinical Practice. JAMA. 2021;325(12):1151-1152. doi: 10.1001/jama.2021.1169Baldwin G.T., Seth P., Noonan R.K. Continued Increases in Overdose Deaths Related to Synthetic Opioids: Implications for Clinical Practice // JAMA. 2021. Vol. 325, N 12. P. 1151–1152. doi: 10.1001/jama.2021.1169Brummett CM, Waljee JF, Goesling J, et al. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA Surg. 2017;152(6):e170504. doi: 10.1001/jamasurg.2017.0504Brummett C.M., Waljee J.F., Goesling J., et al. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults // JAMA Surg. 2017. Vol. 152, N 6. P. e170504. doi: 10.1001/jamasurg.2017.0504Mudumbai SC, Oliva EM, Lewis ET, et al. Time-to-Cessation of Postoperative Opioids: A Population-Level Analysis of the Veterans Affairs Health Care System. Pain Med. 2016;17(9):1732–1743. doi: 10.1093/pm/pnw015Mudumbai S.C., Oliva E.M., Lewis E.T., et al. Time-to-Cessation of Postoperative Opioids: A Population-Level Analysis of the Veterans Affairs Health Care System // Pain Med. 2016. Vol. 17, N 9. P. 1732–1743. doi: 10.1093/pm/pnw015Chan FJ, Schwartz AM, Wong J, et al. Use of Chronic Methadone Before Total Knee Arthroplasty. J Arthroplasty. 2017;32(7):2105–2107. doi: 10.1016/j.arth.2017.02.048Chan F.J., Schwartz A.M., Wong J., et al. Use of Chronic Methadone Before Total Knee Arthroplasty // J Arthroplasty. 2017. Vol. 32, N 7. P. 2105–2107. doi: 10.1016/j.arth.2017.02.048Rapp SE, Ready BL, Nessly ML. Acute pain management in patients with prior opioid consumption: a case-controlled retrospective review. Pain. 1995;61(2):195–201. doi: 10.1016/0304-3959(94)00168-eRapp S.E., Ready B.L., Nessly M.L. Acute pain management in patients with prior opioid consumption: a case-controlled retrospective review // Pain. 1995. Vol. 61, N 2. P. 195–201. doi: 10.1016/0304-3959(94)00168-eLee D, Armaghani S, Archer KR, et al. Preoperative Opioid Use as a Predictor of Adverse Postoperative Self-Reported Outcomes in Patients Undergoing Spine Surgery. J Bone Joint Surg Am. 2014;96(11):e89. doi: 10.2106/JBJS.M.00865Lee D., Armaghani S., Archer K.R., et al. Preoperative Opioid Use as a Predictor of Adverse Postoperative Self-Reported Outcomes in Patients Undergoing Spine Surgery // J Bone Joint Surg Am. 2014. Vol. 96, N 11. P. e89. doi: 10.2106/JBJS.M.00865VanDenKerkhof EG, Hopman WM, Goldstein DH, et al. Impact of perioperative pain intensity, pain qualities, and opioid use on chronic pain after surgery: a prospective cohort study. Reg Anesth Pain Med. 2012;37(1):19–27. doi: 10.1097/AAP.0b013e318237516eVanDenKerkhof E.G., Hopman W.M., Goldstein D.H., et al. Impact of perioperative pain intensity, pain qualities, and opioid use on chronic pain after surgery: a prospective cohort study // Reg Anesth Pain Med. 2012. Vol. 37, N 1. P. 19–27. doi: 10.1097/AAP.0b013e318237516eZywiel MG, Stroh DA, Lee SY, et al. Chronic opioid use prior to total knee arthroplasty. J Bone Joint Surg Am. 2011;93(21):1988–1993. doi: 10.2106/JBJS.J.01473Zywiel M.G., Stroh D.A., Lee S.Y., et al. Chronic opioid use prior to total knee arthroplasty // J Bone Joint Surg Am. 2011. Vol. 93, N 21. P. 1988–1993. doi: 10.2106/JBJS.J.01473Lee H. Opioid-induced hyperalgesia is a paradox for perioperative physician. Korean J Anesthesiol. 2013;64(1):1–2. doi: 10.4097/kjae.2013.64.1.1Lee H. Opioid-induced hyperalgesia is a paradox for perioperative physician // Korean J Anesthesiol. 2013. Vol. 64, N 1. P. 1–2. doi: 10.4097/kjae.2013.64.1.1Koepke EJ, Manning EL, Miller TE, et al. The rising tide of opioid use and abuse: the role of the anesthesiologist. Perioper Med (Lond). 2018;7:16. doi: 10.1186/s13741-018-0097-4Koepke E.J., Manning E.L., Miller T.E., et al. The rising tide of opioid use and abuse: the role of the anesthesiologist // Perioper Med (Lond). 2018. Vol. 7, N. P. 16. doi: 10.1186/s13741-018-0097-4Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain. 2008;24(6):479–496. doi: 10.1097/AJP.0b013e31816b2f43Chu L.F., Angst M.S., Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations // Clin J Pain. 2008. Vol. 24, N 6. P. 479–496. doi: 10.1097/AJP.0b013e31816b2f43Chia YY, Liu K, Wang JJ, et al. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anaesth. 1999;46(9):872–877. doi: 10.1007/BF03012978Chia Y.Y., Liu K., Wang J.J., et al. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance // Can J Anaesth. 1999. Vol. 46, N 9. P. 872–877. doi: 10.1007/BF03012978Bekhit MH. Opioid-induced hyperalgesia and tolerance. Am J Ther. 2010;17(5):498–510. doi: 10.1097/MJT.0b013e3181ed83a0Bekhit M.H. Opioid-induced hyperalgesia and tolerance // Am J Ther. 2010. Vol. 17, N 5. P. 498–510. doi: 10.1097/MJT.0b013e3181ed83a0George S, Johns M. Review of nonopioid multimodal analgesia for surgical and trauma patients. Am J Health Syst Pharm. 2020;77(24):2052–2063. doi: 10.1093/ajhp/zxaa301George S., Johns M. Review of nonopioid multimodal analgesia for surgical and trauma patients // Am J Health Syst Pharm. 2020. Vol. 77, N 24. P. 2052-2063. doi: 10.1093/ajhp/zxaa301Saurabh S, Smith JK, Pedersen M, et al. Scheduled intravenous acetaminophen reduces postoperative narcotic analgesic demand and requirement after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2015;11(2):424–430. doi: 10.1016/j.soard.2014.09.017Saurabh S., Smith J.K., Pedersen M., et al. Scheduled intravenous acetaminophen reduces postoperative narcotic analgesic demand and requirement after laparoscopic Roux-en-Y gastric bypass // Surg Obes Relat Dis. 2015. Vol. 11, N 2. P. 424–430. doi: 10.1016/j.soard.2014.09.017Wick EC, Grant MC, Wu CL. Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review. JAMA Surg. 2017;152(7):691–697. doi: 10.1001/jamasurg.2017.0898Wick E.C., Grant M.C., Wu C.L. Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review // JAMA Surg. 2017. Vol. 152, N 7. P. 691–697. doi: 10.1001/jamasurg.2017.0898De Oliveira GS, Jr., Castro-Alves LJ, Khan JH, McCarthy RJ. Perioperative systemic magnesium to minimize postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology. 2013;119(1):178–190. doi: 10.1097/ALN.0b013e318297630dDe Oliveira G.S., Jr., Castro-Alves L.J., Khan J.H., McCarthy R.J. Perioperative systemic magnesium to minimize postoperative pain: a meta-analysis of randomized controlled trials // Anesthesiology. 2013. Vol. 119, N 1. P. 178–190. doi: 10.1097/ALN.0b013e318297630dNielsen RV, Fomsgaard JS, Siegel H, et al. Intraoperative ketamine reduces immediate postoperative opioid consumption after spinal fusion surgery in chronic pain patients with opioid dependency: a randomized, blinded trial. Pain. 2017;158(3):463–470. doi: 10.1097/j.pain.0000000000000782Nielsen R.V., Fomsgaard J.S., Siegel H., et al. Intraoperative ketamine reduces immediate postoperative opioid consumption after spinal fusion surgery in chronic pain patients with opioid dependency: a randomized, blinded trial // Pain. 2017. Vol. 158, N 3. P. 463–470. doi: 10.1097/j.pain.0000000000000782Heesen M, Rijs K, Hilber N, et al. Effect of intravenous dexamethasone on postoperative pain after spinal anaesthesia – a systematic review with meta-analysis and trial sequential analysis. Anaesthesia. 2019;74(8):1047–1056. doi: 10.1111/anae.14666Heesen M., Rijs K., Hilber N., et al. Effect of intravenous dexamethasone on postoperative pain after spinal anaesthesia a systematic review with meta-analysis and trial sequential analysis // Anaesthesia. 2019. Vol. 74, N 8. P. 1047–1056. doi: 10.1111/anae.14666Bi Y, Ye Y, Ma J, et al. Effect of perioperative intravenous lidocaine for patients undergoing spine surgery: A meta-analysis and systematic review. Medicine (Baltimore). 2020;99(48):e23332. doi: 10.1097/MD.0000000000023332Bi Y., Ye Y., Ma J., et al. Effect of perioperative intravenous lidocaine for patients undergoing spine surgery: A meta-analysis and systematic review // Medicine (Baltimore). 2020. Vol. 99, N 48. P. e23332. doi: 10.1097/MD.0000000000023332Shah A, Hayes CJ, Martin BC. Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use – United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66(10):265–269. doi: 10.15585/mmwr.mm6610a1Shah A., Hayes C.J., Martin B.C. Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use United States, 2006-2015 // MMWR Morb Mortal Wkly Rep. 2017. Vol. 66, N 10. P. 265–269. doi: 10.15585/mmwr.mm6610a1Kumar K, Gulotta LV, Dines JS, et al. Unused Opioid Pills After Outpatient Shoulder Surgeries Given Current Perioperative Prescribing Habits. Am J Sports Med. 2017;45(3):636–641. doi: 10.1177/0363546517693665Kumar K., Gulotta L.V., Dines J.S., et al. Unused Opioid Pills After Outpatient Shoulder Surgeries Given Current Perioperative Prescribing Habits // Am J Sports Med. 2017. Vol. 45, N 3. P. 636–641. doi: 10.1177/0363546517693665Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432-442. doi: 10.1111/j.1526–4637.2005.00072.xWebster L.R., Webster R.M. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool // Pain Med. 2005. Vol. 6, N 6. P. 432–442. doi: 10.1111/j.1526-4637.2005.00072.xTighe PJ, Le-Wendling LT, Patel A, et al. Clinically derived early postoperative pain trajectories differ by age, sex, and type of surgery. Pain. 2015;156(4):609–617. doi: 10.1097/01.j.pain.0000460352.07836.0dTighe P.J., Le-Wendling L.T., Patel A., et al. Clinically derived early postoperative pain trajectories differ by age, sex, and type of surgery // Pain. 2015. Vol. 156, N 4. P. 609–617. doi: 10.1097/01.j.pain.0000460352.07836.0dWebster LR. Risk Factors for Opioid-Use Disorder and Overdose. Anesth Analg. 2017;125(5):1741–1748. doi: 10.1213/ANE.0000000000002496Webster L.R. Risk Factors for Opioid-Use Disorder and Overdose // Anesth Analg. 2017. Vol. 125, N 5. P. 1741–1748. doi: 10.1213/ANE.0000000000002496Blendon RJ, Benson JM. The Public and the Opioid-Abuse Epidemic. N Engl J Med. 2018;378(5):407–411. doi: 10.1056/NEJMp1714529Blendon R.J., Benson J.M. The Public and the Opioid-Abuse Epidemic // N Engl J Med. 2018. Vol. 378, N 5. P. 407–411. doi: 10.1056/NEJMp1714529Wang J, Chen Z. Neuromodulation for Pain Management. Adv Exp Med Biol. 2019;1101:207–223. doi: 10.1007/978-981-13-2050-7_8Wang J., Chen Z. Neuromodulation for Pain Management // Adv Exp Med Biol. 2019. Vol. 1101, N. P. 207–223. doi: 10.1007/978-981-13-2050-7_8Hong T, Wang H, Li G, et al. Systematic Review and Meta-Analysis of 12 Randomized Controlled Trials Evaluating the Efficacy of Invasive Radiofrequency Treatment for Knee Pain and Function. Biomed Res Int. 2019;2019:9037510. doi: 10.1155/2019/9037510Hong T., Wang H., Li G., et al. Systematic Review and Meta-Analysis of 12 Randomized Controlled Trials Evaluating the Efficacy of Invasive Radiofrequency Treatment for Knee Pain and Function // Biomed Res Int. 2019. Vol. 2019, N. P. 9037510. doi: 10.1155/2019/9037510McMillan S, Dwyer T, Amin NH, Ford E. The Evolution of Cryoneurolysis for the Treatment of Shoulder, Hip, and Knee Pain: Where Are We Now and Where Will We Go? A Systematic Review. Surg Technol Int. 2020;37:361–366.McMillan S., Dwyer T., Amin N.H., Ford E. The Evolution of Cryoneurolysis for the Treatment of Shoulder, Hip, and Knee Pain: Where Are We Now and Where Will We Go? A Systematic Review // Surg Technol Int. 2020. Vol. 37, N. P. 361-366.Cai Q, Liu GQ, Huang LS, et al. Effects of erector spinae plane block on postoperative pain and side-effects in adult patients underwent surgery: A systematic review and meta-analysis of randomized controlled trials. Int J Surg. 2020;80:107–116. doi: 10.1016/j.ijsu.2020.05.038Cai Q., Liu G.Q., Huang L.S., et al. Effects of erector spinae plane block on postoperative pain and side-effects in adult patients underwent surgery: A systematic review and meta-analysis of randomized controlled trials // Int J Surg. 2020. Vol. 80, N. P. 107–116. doi: 10.1016/j.ijsu.2020.05.038Baeriswyl M, Zeiter F, Piubellini D, et al. The analgesic efficacy of transverse abdominis plane block versus epidural analgesia: A systematic review with meta-analysis. Medicine (Baltimore). 2018;97(26):e11261. doi: 10.1097/MD.0000000000011261Baeriswyl M., Zeiter F., Piubellini D., et al. The analgesic efficacy of transverse abdominis plane block versus epidural analgesia: A systematic review with meta-analysis // Medicine (Baltimore). 2018. Vol. 97, N 26. P. e11261. doi: 10.1097/MD.0000000000011261Lam KHS, Hung CY, Chiang YP, et al. Ultrasound-Guided Nerve Hydrodissection for Pain Management: Rationale, Methods, Current Literature, and Theoretical Mechanisms. J Pain Res. 2020;13:1957–1968. doi: 10.2147/JPR.S247208Lam K.H.S., Hung C.Y., Chiang Y.P., et al. Ultrasound-Guided Nerve Hydrodissection for Pain Management: Rationale, Methods, Current Literature, and Theoretical Mechanisms // J Pain Res. 2020. Vol. 13, N. P. 1957–1968. doi: 10.2147/JPR.S247208Yang Y, Botton MR, Scott ER, Scott SA. Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing. Pharmacogenomics. 2017;18(7):673–685. doi: 10.2217/pgs-2017-0033Yang Y., Botton M.R., Scott E.R., Scott S.A. Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing // Pharmacogenomics. 2017. Vol. 18, N 7. P. 673–685. doi: 10.2217/pgs-2017-0033Aviram J, Pud D, Gershoni T, et al. Medical cannabis treatment for chronic pain: Outcomes and prediction of response. Eur J Pain. 2021;25(2):359–374. doi: 10.1002/ejp.1675Aviram J., Pud D., Gershoni T., et al. Medical cannabis treatment for chronic pain: Outcomes and prediction of response // Eur J Pain. 2021. Vol. 25, N 2. P. 359–374. doi: 10.1002/ejp.1675Deer TR, Hunter CW, Mehta P, et al. A Systematic Literature Review of Dorsal Root Ganglion Neurostimulation for the Treatment of Pain. Pain Med. 2020;21(8):1581–1589. doi: 10.1093/pm/pnaa005Deer T.R., Hunter C.W., Mehta P., et al. A Systematic Literature Review of Dorsal Root Ganglion Neurostimulation for the Treatment of Pain // Pain Med. 2020. Vol. 21, N 8. P. 1581–1589. doi: 10.1093/pm/pnaa005